Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Pharm (Weinheim) ; 354(10): e2100145, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34131943

ABSTRACT

A series of novel pyrazolo[3,4-d]pyrimidin-4-one derivatives were synthesized and evaluated for their anti-phosphodiesterase-5 (PDE-5) activity. A total of 28 compounds, containing alkyl and aryl groups at the 1-N and 3-C positions on the pyrazole ring, and also bearing different alkyl substituents on the piperazine ring were synthesized. Four compounds (4d, 5d, 6d, and 5o) were found to have better inhibitory activity against PDE-5 (IC50 < 10 nM). All four of the most active compounds contain a phenyl ring at the N1 position. Compounds containing a 3,5-dimethylpiperazinyl group show better activity than others. These results suggest that compound 5o can be used as a lead structure for developing new inhibitors of PDE-5.


Subject(s)
Phosphodiesterase 5 Inhibitors/pharmacology , Pyrazoles/pharmacology , Pyrimidines/pharmacology , Sildenafil Citrate/pharmacology , Inhibitory Concentration 50 , Phosphodiesterase 5 Inhibitors/chemical synthesis , Phosphodiesterase 5 Inhibitors/chemistry , Pyrazoles/chemical synthesis , Pyrazoles/chemistry , Pyrimidines/chemical synthesis , Pyrimidines/chemistry , Sildenafil Citrate/chemistry , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...